The Lancet. Global healthHumansCost-Benefit AnalysisTuberculosisKenyaBudgets
The effectiveness, cost-effectiveness, budget impact, and return on investment of scaling up tuberculosis screening and preventive treatment in Brazil, Georgia, Kenya, and South Africa: a modelling study.
Juan F Vesga, Mona Salaheldin Mohamed, Monica Shandal, Elias Jabbour, Nino Lomtadze, Mmamapudi Kubjane, Anete Trajman, Gesine Meyer-Rath, Zaza Avaliani, Wesley Rotich, Daniel Mwai, Julio Croda, Hlengani T Mathema, Immaculate Kathure, Rhoda Pola
Published: 202510.1016/S2214-109X(25)00321-3
Abstract
BACKGROUND: Closing the tuberculosis diagnostic gap and scaling up tuberculosis preventive treatment (TPT) are two global priorities to end tuberculosis. We aimed to estimate the cost-effectiveness, budget impact, and societal return on investment of…
Preview only. Read the full abstract at the source